Researchers test potential of artificial blood vessels

04/25/2013 | HealthDay News

Artificial blood vessels made using a biodegradable mesh tube as a scaffold for aorta cells have shown positive results in an animal study and a clinical trial has begun, according to findings presented online through the American Heart Association. The process for the new blood vessel to develop and the mesh structure to dissolve takes two months. Tests on primates showed the synthetic blood vessels can endure frequent needle sticks. A clinical trial in Europe is underway, and a study in the U.S. has been granted FDA authorization.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA